ARTIVION INC
AORTNYSETrading Snapshot
- Day Range
- $28.16 – $28.99
- 52-Week Range
- $19.16 – $48.25
- Volume
- $3.34B
- Avg Volume
- $2.44B
- Shares Outstanding
- 48.5M
- Next Earnings
- Sep 20, 2026
Fundamentals Snapshot
- Annual Revenue
- $439M
- Last Q Revenue
- $114M
- P/E Ratio
- 97.3
- P/S Ratio
- 2.5x
- EPS (TTM)
- $0.24
- Dividend Yield
- —
Why Investors Own AORT
- ✓High-growth profile — revenue up +12.2% YoY with expanding US Equity exposure.
- ✓Healthy economics — 53% gross margin and 11% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About ARTIVION INC
A company profile for ARTIVION INC isn’t available yet — check back soon.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
Alger Dynamic Opportunities Fund Q2 2026 Portfolio Update
Class A shares of the Alger Dynamic Opportunities Fund outperformed the S&P 500 Index during the second quarter of 2026. Read more here.
Artivion, Inc. (AORT) Q2 2026 Earnings Call Transcript
Artivion, Inc. (AORT) Q2 2026 Earnings Call August 6, 2026 4:30 PM EDTCompany ParticipantsJames Mackin - Chairman, President & CEOLance Berry - EVP,...
Artivion, Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-08-07. The following slide deck was published by Artivion, Inc.
Artivion Affirms FY2026 Sales Guidance of $480.000M-$496.000M vs $486.232M Est
Artivion (NYSE:AORT) affirms FY2026 sales outlook from $480.000 million-$496.000 million to $480.000 million-$496.000 million vs $486.232 million estimate.
Conestoga Micro Cap Composite Q2 2026 Leaders, Laggards, Buys And Sells
Conestoga Micro Cap Composite highlights top performers like Twist Bioscience and key portfolio shifts during Q2 2026. Read the full analysis for more details.
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results
Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2026 financial results will be released on Thursday, August 6, 2026, after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question-and-answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.